Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, April 17, 2019
PerkinElmer announced it has joined Accenture’s open partner ecosystem, designed to help solution providers, software vendors and life sciences companies accelerate drug discovery.
read more
Thursday, September 07, 2017
PerkinElmer expanded its Whole Genome Sequencing (WGS) services to families that preserve their cord blood and cord tissue with ViaCord.
read more
Wednesday, March 24, 2021
PerkinElmer announced documentation, workflow and decision-making Signals informatics platform is being expanded to build on existing capabilities in the biologics drug discovery space.
read more
PerkinElmer announced the Company’s EONIS screening assay for newborns that simultaneously tests for SMA, SCID, and XLA has received CE-IVD approval.
read more
Monday, December 10, 2018
PerkinElmer announced that its board of directors has named Prahlad Singh president and chief operating officer, effective January 1, 2019.
read more
Wednesday, April 11, 2018
PerkinElmer announced the appointment of James M. Mock to senior vice president and chief financial officer, effective May 1, 2018.
read more
PerkinElmer reported financial results for the fourth quarter and full year ended December 31, 2017.
read more
Monday, December 23, 2019
PerkinElmer has announced a collaboration with Emerald Scientific, a cannabis and hemp lab technology provider.
read more
PerkinElmer announced Michel Vounatsos has been elected to its board of directors, effective March 1, 2020.
read more
PerkinElmer has acquired Shanghai Spectrum Instruments.
read more
Pergamum AB, a portfolio company of Karolinska Development AB, announced today that the primary safety and tolerability end-point was met in the randomized Phase I/II trial of LL-37 for treatment of venous leg ulcers. The data also show that patients...
read more
Pergamum AB announced today that several end-points were met in a randomized Phase II trial of PXL-01 for prevention of post-surgical adhesions. Karolinska Development AB is the majority owner of Pergamum.
read more
Wednesday, January 12, 2022
Performance Cell Manufacturing a contract development and manufacturing organization announced that it has been acquired by Great Point Partners (“GPP”), a Greenwich, Connecticut based private investment firm focused on the healthcare industry.
read more
Peregrine Pharmaceuticals has reduced its overall workforce by 60 employees.
read more
Thursday, October 15, 2026
Perceptive Discovery and Nucleus RadioPharma have formed a nonexclusive partnership linking preclinical testing with clinical manufacturing for radiopharmaceutical developers.
read more